학술논문

Single-Agent Trabectedin Versus Physician's Choice Chemotherapy in Patients With Recurrent Ovarian Cancer With BRCA -Mutated and/or BRCAness Phenotype: A Randomized Phase III Trial
Document Type
Article
Source
In: Journal of Clinical Oncology. (Journal of Clinical Oncology, 1 May 2024, 42(13):1488-1498)
Subject
Language
English
ISSN
15277755
0732183X